p73 G4C14-A4T14 polymorphism and cancer risk: A meta-analysis based on 27 case-control studies

Mutagenesis

Volumn 26, Issue 4, 2011, Pages 573-581

  Liu, Fei ^a   Liu, Liu ^b   Li, Bo ^a   Wei, Yong Gang ^a   Yan, Lv Nan ^a   Wen, Tian Fu ^a   Xu, Ming Qing ^a   Wang, Wen Tao ^a   Yang, Jia Yin ^a  

^a SICHUAN UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P73;

ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CLINICAL ARTICLE; COLORECTAL CANCER; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HEAD AND NECK CANCER; HOMOZYGOTE; HUMAN; INDIVIDUALIZATION; JAPANESE; MALE; META ANALYSIS; NECK CANCER; POPULATION; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; RISK FACTOR; STATISTICAL SIGNIFICANCE; STRENGTH; UNITED KINGDOM;

ALLELES; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 79959702329     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger018     Document Type: Article

References (48)

1. Jost, C. A., Marin, M. C. and Kaelin, W. G., Jr. (1997) p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature, 389, 191-194.
2. Zhu, J., Jiang, J., Zhou, W. and Chen, X. (1998) The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res., 58, 5061-5065.
3. Wang, X. Q., Ongkeko, W. M., Lau, A. W., Leung, K. M. and Poon, R. Y. (2001) A possible role of p73 on the modulation of p53 level through MDM2. Cancer Res., 61, 1598-1603.
4. Cai, Y. C., Yang, G. Y., Nie, Y. et al. (2000) Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis, 21, 683-689.
5. Mai, M., Yokomizo, A., Qian, C. et al. (1998) Activation of p73 silent allele in lung cancer. Cancer Res., 58, 2347-2349.
6. Nomoto, S., Haruki, N., Kondo, M. et al. (1998) Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res., 58, 1380-1383.
7. Takahashi, H., Ichimiya, S., Nimura, Y. et al. (1998) Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res., 58, 2076-2077.
8. Peters, M. A., Janer, M., Kolb, S. et al. (2001) Germline mutations in the p73 gene do not predispose to familial prostate-brain cancer. Prostate, 48, 292-296.
9. Li, Q., Athan, E. S., Wei, M. et al. (2004) TP73 allelic expression in human brain and allele frequencies in Alzheimer's disease. BMC Med. Genet., 5, 14.
10. Kaghad, M., Bonnet, H., Yang, A. et al. (1997) Monoallelically expressed gene related to p53 at 1q36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90, 809-819.
11. Arfaoui, A. T., Ben Mahmoud, L. K., Ben Hmida, A. et al. (2010) Relationship between p73 polymorphism and the immunohistochemical profile of the full-length (TAp73) and NH2-truncated (ΔNp73) isoforms in Tunisian patients. Appl. Immunohistochem. Mol. Morphol., 18, 546-554.
12. Lee, K. E., Hong, Y. S., Kim, B. G. et al. (2010) p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival. World J. Gastroenterol., 16, 4448-4454.
13. Pfeifer, D., Arbman, G. and Sun, X. F. (2005) Polymorphism of the p73 gene in relation to colorectal cancer risk and survival. Carcinogenesis, 26, 103-107.
14. Liu, X. Y. and He, L. P. (2008) Polymorphism and protein expression of p73 gene in relation to colorectal tumor. J. Fujian Med. Univ., 42, 515-517.
15. Hamajima, N., Matsuo, K., Suzuki, T. et al. (2002) No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett., 181, 81-85.
16. Jun, H. J., Park, S. H., Lee, W. K. et al. (2007) Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer. Mol. Carcinog. 46, 100-105.
17. Hu, Z., Miao, X., Ma, H. et al. (2005) Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population. Int. J. Cancer, 114, 455-460.
18. Li, G., Wang, L. E., Chamberlain, R. M., Amos, C. I., Spitz, M. R. and Wei, Q. (2004) p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res., 64, 6863-6866.
19. Hiraki, A., Matsuo, K., Hamajima, N. et al. (2003) Different risk relations with smoking for non-small-cell lung cancer: comparison of TP53 and TP73 genotypes. Asian Pac. J. Cancer Prev., 4, 107-112.
20. De Feo, E., Persiani, R., La Greca, A. et al. (2009) A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression. Mutat. Res., 675, 60-65.
21. Ge, H., Wang, Y. M., Cao, Y. Y. et al. (2006) Correlation of p73 polymorphisms to genetic susceptibilities to esophageal carcinoma and gastric cardiac carcinoma. Ai Zheng, 25, 1351-1355.
22. Zhang, W. H., Liu, Y. H., Guo, F. X. et al. (2009) Association of p73 gene G4C14-to-A4T14 polymorphism with increased gastric cancer risk in northwestern Chinese population. J. Lanzhou Univ. (Med. Sci.), 35, 39-42.
23. Ge, H., Wang, Y. M., Cao, Y. Y. et al. (2007) The p73 polymorphisms are not associated with susceptibility to esophageal squamous cell carcinoma in a high incidence region of China. Dis. Esophagus, 20, 290-296.
24. Ryan, B. M., McManus, R., Daly, J. S. et al. (2001) A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma. Br. J. Cancer, 85, 1499-1503.
25. Niwa, Y., Hirose, K., Matsuo, K. et al. (2005) Association of p73 G4C14- to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects. Cancer Lett., 219, 183-190.
26. Gallì, P., Cadoni, G., Volante, M. et al. (2009) A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population. BMC Cancer, 9, 137.
27. Li, G., Sturgis, E. M., Wang, L. E. et al. (2004) Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis, 25, 1911-1916.
28. Misra, C., Majumder, M., Bajaj, S., Ghosh, S., Roy, B. and Roychoudhury, S. (2009) Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral Cancer. Mol. Carcinog., 48, 790-800.
29. Chen, X., Sturgis, E. M., El-Naggar, A. K., Wei, Q. and Li, G. (2008) Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis, 29, 2120-2125.
30. Hishida, A., Matsuo, K., Tajima, K. et al. (2004) Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese. Leuk. Lymphoma, 45, 957-964.
31. Li, C., Chen, K., Liu, Z. et al. (2008) Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma. J. Invest. Dermatol., 128, 1585-1588.
32. Kang, S., Wang, D. J., Li, W. S. et al. (2009) Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women. Int. J. Gynecol. Cancer, 19, 572-577.
33. Chen, X., Sturgis, E. M., Etzel, C. J., Wei, Q. and Li, G. (2008) p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers. Cancer, 113, 3307-3314.
34. Huang, X. E., Hamajima, N., Katsuda, N. et al. (2003) Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer, 10, 307-311.
35. Niwa, Y., Hamajima, N., Atsuta, Y. et al. (2004) Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. Cancer Lett., 205, 55-60.
36. Higgins, J. P. and Thompson, S. G. (2002) Quantifying heterogeneity in a meta-analysis. Stat. Med., 21, 1539-1558.
37. Mantel, N. and Haenszel, W. (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl Cancer Inst., 22, 719-748.
38. DerSimonian, R. and Laird, N. (1986) Meta-analysis in clinical trials. Control. Clin. Trials, 7, 177-188.
39. Begg, C. B. and Mazumdar, M. (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-1101.
40. Egger, M., Davey Smith, G., Schneider, M. and Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-634.
41. Moll, U. M. and Slade, N. (2004) p63 and p73: roles in development and tumor formation. Mol. Cancer Res., 2, 371-386.
42. Yang, A., Walker, N. and Bronson, R. (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumors. Nature, 404, 99-103.
43. Pozniak, C. D., Radinovic, S., Yang, A. et al. (2000) An anti-apoptotic role of the p53 family member, p73, during developmental neuron death. Science, 289, 304-306.
44. Ozaki, T. and Nakagawara, A. (2005) p73, a sophisticated p53 family member in the cancer world. Cancer Sci., 96, 729-737.
45. Cohen, S. M., Shirai, T. and Steineck, G. (2000) Epidemiology and etiology of premalignant and malignant urothelial changes. Scand. J. Urol. Nephrol. Suppl., 205, 105-115.
46. Wei, Q., Cheng, L., Amos, C. I., Wang, L. E., Guo, Z., Hong, W. K. et al. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J. Natl Cancer Inst., 92, 1764-1772.
47. Zeidel, A., Beilin, B., Yardeni, I., Mayburd, E., Smirnov, G. and Bessler, H. (2002) Immune response in asymptomatic smokers. Acta Anaesthesiol. Scand., 46, 959-964.
48. Quinones, L. A., Irarrazabal, C. E., Rojas, C. R. et al. (2006) Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study. Asian J. Androl., 8, 349-355.